Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 8-K Event Results of operations
  2. 8-K Event Regulation FD disclosure
  3. SC 13G/A Stake Amended Statement of Ownership
  4. NT 10-Q Other NT 10-Q
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G Stake Amended Statement of Ownership
  8. SC 13G Stake Amended Statement of Ownership
  9. 8-K Event Regulation FD disclosure
  10. SC 13G Stake Amended Statement of Ownership
  11. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Regulation FD disclosure
  15. SC 13G Stake Amended Statement of Ownership
  16. 8-K Event Regulation FD disclosure
  17. 8-K Event Regulation FD disclosure
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 7 of 38 · 752 filings